Dahlman Rose & Co. is out with a research report on Energy XXI EXXI, and calls the company compelling at these levels. It has a $23 price target and Buy rating after the company reported inline earnings.
In the research report, Dahlman Rose writes, "We estimate an NAV of $22/sh at the current NYMEX strip, which continues to include heavy risking of the Ultra-Deep Shelf. We also estimate EXXI currently trades at 5.6x 2011 EV/EBITDAX (year ending Dec 2011) and thus is already getting some credit for its exploration catalysts, but upside remains."
Don't miss these trading ideas!
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in